Showing 19,801 - 19,820 results of 19,944 for search '(( 100 ((ng decrease) OR (we decrease)) ) OR ( 50 ((mean decrease) OR (a decrease)) ))', query time: 0.54s Refine Results
  1. 19801

    AOX inhibitor supresses growth of <i>T</i>. <i>hominis</i> cells inside the RK13 host cells at early meront stages of the infection, and affects the ability to infect by the spores... by Kacper M. Sendra (14285356)

    Published 2022
    “…<p>Effects of the two clinically used anti-microsporidian drugs (albendazole, 350 nM; and fumagillin, 200 nM), and an inhibitor of the AOX Colletochlorin B (CCB, 50 μM) on progression of the parasite life cycle were tested in a synchronised time course of infection in <i>T</i>. …”
  2. 19802

    Table_1_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx by Ruixin Song (15399459)

    Published 2023
    “…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”
  3. 19803

    DataSheet1_Photochemical Reactivity of Humic Substances in an Aquatic System Revealed by Excitation-Emission Matrix Fluorescence.docx by Xin-yuan Wang (10888515)

    Published 2021
    “…The half-life times of C1, C2, and C3 ranged from 6.61–11.77 h to 4.50–8.81 h for FA and HA, respectively. Combining an excitation-emission matrix with FRI and PARAFAC analyses is a powerful approach for elucidating changes to humic substances during their irradiation, which is helpful for predicting the environmental toxicity of contaminants in natural ecosystems.…”
  4. 19804

    Table_3_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx by Ruixin Song (15399459)

    Published 2023
    “…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”
  5. 19805

    Table_1_Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.docx by Fei-Fei Xu (538090)

    Published 2022
    “…After a median follow-up of 69 months, the 5-year rate of DFS, BCSS, and LRR in the overall cohort was 90.2%, 97.4%, and 3.6%, respectively. …”
  6. 19806

    Table_2_Durability of immune response after SARS-CoV-2 vaccination in patients with chronic liver disease.docx by Ruixin Song (15399459)

    Published 2023
    “…Within 30 days of booster immunization, the positive rates of nCoV NTAb and nCoV S-RBD in patients with CLD rapidly increased from 29.0% and 48.4% at the end of basic immunization to 95.2% and 90.5%, and maintained a high level (defined as the positive rate >50%) until 120 days when the positive rates of nCoV NTAb and nCoV S-RBD were still high at 79.5% and 87.2%, respectively. …”
  7. 19807

    Targeting pan-caspase activation suppresses HIV-1 infection. by Jason Segura (14608801)

    Published 2023
    “…Primary CD8-depleted PBMC were infected with HIV-1<sub>BAL</sub> for 6 days in the presence of 50uM indicated caspase inhibitors and analyzed for the accumulation of p24+/CD62L- populations (<b>A</b>) as well as the level of infection using intracellular p24 staining (<b>B</b>). …”
  8. 19808

    DataSheet_1_Prognostic Value of Leucocyte to High-Density Lipoprotein-Cholesterol Ratios in COVID-19 Patients and the Diabetes Subgroup.docx by Yuxiu Wang (8088287)

    Published 2021
    “…</p>Methods<p>We conducted a multicenter retrospective cohort study involving all hospitalized patients with COVID-19 from January to March 2020 in five hospitals in Wuhan, China. …”
  9. 19809

    Image_1_T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease.TIF by Jiachuan Xiong (748476)

    Published 2021
    “…The primary outcomes were the major infection and renal outcome.</p><p>Results: A total of 410 CKD patients were enrolled; the average age was 47.25 years. …”
  10. 19810

    DataSheet_2_WASp Deficiency Selectively Affects the TCR Diversity of Different Memory T Cell Subsets in WAS Chimeric Mice.docx by Wenyan Li (255305)

    Published 2022
    “…Bioinformatic analyses showed that compared with wild type (WT), WAS knock out (KO)-CD4<sup>+</sup> TEM cells exhibited increased Simpson index and decreased D50 index (P <0.05); The rank abundance curve of KO-CD4<sup>+</sup> TEM cells was shorter and steeper than that of WT, and the angle of <sup>q</sup>D and q in KO-CD4<sup>+</sup> TEM cells was lower than that of WT, while these indexes showed few changes between WT and KO chimeric mice in the CD8<sup>+</sup>TCM population. …”
  11. 19811

    datasheet1_Spatio-Temporal Variability of Peat CH4 and N2O Fluxes and Their Contribution to Peat GHG Budgets in Indonesian Forests and Oil Palm Plantations.docx by Erin Swails (10323518)

    Published 2021
    “…The objective of our research was to assess changes in peat GHG flux and budget associated with peat swamp forest disturbance and conversion to oil palm plantation and to evaluate drivers of variation in trace gas fluxes. Over a period of one and a half year, we monitored monthly CH<sub>4</sub> and N<sub>2</sub>O fluxes together with environmental variables in three undrained peat swamp forests and three oil palm plantations on peat in Central Kalimantan. …”
  12. 19812

    Data_Sheet_1_T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease.docx by Jiachuan Xiong (748476)

    Published 2021
    “…The primary outcomes were the major infection and renal outcome.</p><p>Results: A total of 410 CKD patients were enrolled; the average age was 47.25 years. …”
  13. 19813

    Image_2_T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease.TIFF by Jiachuan Xiong (748476)

    Published 2021
    “…The primary outcomes were the major infection and renal outcome.</p><p>Results: A total of 410 CKD patients were enrolled; the average age was 47.25 years. …”
  14. 19814

    DataSheet_1_WASp Deficiency Selectively Affects the TCR Diversity of Different Memory T Cell Subsets in WAS Chimeric Mice.zip by Wenyan Li (255305)

    Published 2022
    “…Bioinformatic analyses showed that compared with wild type (WT), WAS knock out (KO)-CD4<sup>+</sup> TEM cells exhibited increased Simpson index and decreased D50 index (P <0.05); The rank abundance curve of KO-CD4<sup>+</sup> TEM cells was shorter and steeper than that of WT, and the angle of <sup>q</sup>D and q in KO-CD4<sup>+</sup> TEM cells was lower than that of WT, while these indexes showed few changes between WT and KO chimeric mice in the CD8<sup>+</sup>TCM population. …”
  15. 19815

    UPPAAL SMC model specification by Marc Souvannasouck (16475829)

    Published 2023
    “…Upon the completion of this month, the model transitions to a branchpoint and adds a monthly cost of 50 to the total cost, denoting a constant monthly expense for treatment management. …”
  16. 19816

    Robotic-Assisted Median Arcuate Ligament Release With Celiac Artery Lysis and Celiac Ganglion Neurolysis by G. Kimble Jett (6509428)

    Published 2020
    “…<a href="https://doi.org/10.1016/j.jvs.2008.12.078"><em>J Vasc Surg</em>. 2009;50:124-133.…”
  17. 19817

    Supplemental Material for Juurakko et al., 2021 by Collin L. Juurakko (10941459)

    Published 2021
    “…</p><p></p><p></p><p> </p><p>A list of protein accession identifications for all significantly increased and decreased proteins obtained by MS were assembled and used as inputs for STRING (version 11.0) to predict protein-protein interactions (Franceschini <i>et al.…”
  18. 19818

    Table_8_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.XLSX by Huiling Zheng (49699)

    Published 2024
    “…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”
  19. 19819

    Table_1_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.DOCX by Huiling Zheng (49699)

    Published 2024
    “…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”
  20. 19820

    Table_6_Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.DOCX by Huiling Zheng (49699)

    Published 2024
    “…The effectiveness of hybrid immunity (incomplete vaccination) in mitigating the risk of reinfection was 37.88% (95% CI, 28.88–46.89%) within 270–364 days, and decreased to 33.23%% (95% CI, 23.80–42.66%) within 365–639 days; whereas, the effectiveness after complete vaccination was 54.36% (95% CI, 50.82–57.90%) within 270–364 days, and the effectiveness of booster vaccination was 73.49% (95% CI, 68.95–78.04%) within 90–119 days.…”